Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2024-03-18 Sale | 2024-03-20 4:32 pm | G1 Therapeutics Inc. | GTHX | Umstead John W. V Chief Financial Officer | 6,547 | $3.0169 | $19,752 | 123,896 (Direct) | View |
| 2024-01-03 Sale | 2024-01-08 06:04 am | G1 Therapeutics Inc. | GTHX | Umstead John W. V Chief Financial Officer | 743 | $3.0925 | $2,298 | 204,943 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2024-03-20 Option Award | 2024-03-22 4:08 pm | N/A N/A | G1 Therapeutics Inc. | GTHX | Umstead John W. V Chief Financial Officer | 37,500 | $0 | 161,396 (Direct) | View |
| 2024-01-03 Option Award | 2024-01-08 06:04 am | N/A 2034-01-03 | G1 Therapeutics Inc. | GTHX | Umstead John W. V Chief Financial Officer | 111,800 | $0 | 204,943 (Direct) | View |
| 2023-05-10 Option Award | 2023-05-12 4:19 pm | N/A N/A | G1 Therapeutics Inc. | GTHX | Umstead John V. Chief Financial Officer | 35,000 | $0 | 93,886 (Direct) | View |
| 2023-03-15 Option Award | 2023-03-17 4:20 pm | N/A 2033-03-15 | G1 Therapeutics Inc. | GTHX | Umstead John V. Chief Financial Officer | 150,000 | $0 | 158,886 (Direct) | View |
Ownership | 2023-03-17 4:10 pm | N/A N/A | G1 Therapeutics Inc. | GTHX | Umstead John V. Chief Financial Officer | 0 | $0 | 42,136 (Direct) | View |